Trials / Recruiting
RecruitingNCT05721859
M-Vizion™ Macroscopic Radiographic Study
Medacta M-Vizion™ Macroscopic Radiographic Study, Multi-center, Post-Market Outcomes Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Medacta USA · Industry
- Sex
- All
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
Detailed description
The aim of this study is to evaluate the M-Vizion modular stem performance in patients who undergo total hip replacement according to the standard practice. It is expected that subjects receiving revision hip arthroplasty with the Medacta M-Vizion™ modular hip stem will have less than 5mm of stem subsidence at 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | revision hip arthroplasty | revision hip arthroplasty |
Timeline
- Start date
- 2022-10-12
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2023-02-10
- Last updated
- 2025-05-08
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05721859. Inclusion in this directory is not an endorsement.